Clinical implications from the European Heart Rhythm Association consensus document on antiarrhythmic drug therapy

ÖZCAN E. E., GÖRENEK B.

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.20, sa.1, ss.48-51, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.14744/anatoljcardiol.2018.03285
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.48-51
  • Anahtar Kelimeler: antiarrhythmic drugs, pharmacological antiarrhythmic therapy, proarrhythmia, pharmacokinetics, pharmacodynamics, PROPAFENONE
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

The recently published consensus document by the European Heart Rhythm Association presents a patient-tailored pharmacological antiarrhythmic treatment approach targeting the arrhythmia mechanism. This document comprehensively reviews the indications, side effects, and contraindications of antiarrhythmic drugs. In this paper, we reviewed novel treatment concepts offered by the consensus document.